Tianjin, China

Ping Tai

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ping Tai

Introduction

Ping Tai is a notable inventor based in Tianjin, China. He has made significant strides in the field of biopharmaceuticals, particularly in the treatment of non-alcoholic steatohepatitis. His work has garnered attention for its potential impact on healthcare.

Latest Patents

Ping Tai holds a patent for a method of treating non-alcoholic steatohepatitis using a long-acting mutant human fibroblast growth factor. The patent, which is identified as mPEG-CH—NH-mFGF21, involves administering this innovative treatment to subjects in need. This method represents a promising advancement in the management of this condition.

Career Highlights

Ping Tai is associated with Tasly Biopharmaceuticals Co., Ltd., where he contributes his expertise in biopharmaceutical research and development. His work is characterized by a commitment to improving treatment options for patients suffering from liver diseases.

Collaborations

He collaborates with esteemed colleagues such as Jian Li and Jun Han, who share his dedication to advancing medical science and improving patient outcomes.

Conclusion

Ping Tai's innovative contributions to the field of biopharmaceuticals highlight his role as a key inventor in the treatment of non-alcoholic steatohepatitis. His work continues to pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…